Nilotinib recalls

The FDA has published 2 recalls involving Nilotinib since 2026. The latest was reported on 11 Mar 2026. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2026
Last 12 months2reported
Class I00% of total
Ongoing2latest 11 Mar 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 0 0%Class III 2 100%

Why nilotinib is recalled

Companies

By year

Ongoing nilotinib recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIINilotinib Capsules recalled by Cipla USACipla USAPotency & AssayNationwide
DrugCLASS IIINilotinib Capsules recalled by Cipla USACipla USAPotency & AssayNationwide

All nilotinib recalls, newest first

2 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIINilotinib Capsules recalled by Cipla USACipla USAPotency & AssayNationwide
DrugCLASS IIINilotinib Capsules recalled by Cipla USACipla USAPotency & AssayNationwide

Should you stop taking Nilotinib?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.